Your browser doesn't support javascript.
loading
The Shifting Epidemiology of Hepatitis A in the World Health Organization Western Pacific Region.
Gloriani, Nina G; de Paz-Silava, Sheriah Laine M; Allison, Robert D; Takashima, Yoshihiro; Avagyan, Tigran.
Afiliação
  • Gloriani NG; Institute of Pathology, St. Luke's Medical Center, Quezon City 1112, Philippines.
  • de Paz-Silava SLM; College of Public Health, University of the Philippines Manila, Manila 1000, Philippines.
  • Allison RD; Accelerated Disease Control Branch, Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
  • Takashima Y; Vaccine-Preventable Diseases and Immunization Unit, Division of Programmes for Disease Control, Western Pacific Regional Office, World Health Organization, Manila 1000, Philippines.
  • Avagyan T; Vaccine-Preventable Diseases and Immunization Unit, Division of Programmes for Disease Control, Western Pacific Regional Office, World Health Organization, Manila 1000, Philippines.
Vaccines (Basel) ; 12(2)2024 Feb 16.
Article em En | MEDLINE | ID: mdl-38400187
ABSTRACT
Within the past few decades, improvement in sanitation and economic growth has driven a changing epidemiology of hepatitis A in the Western Pacific Region (WPR) of the World Health Organization (WHO). In this review, we gathered available published information on hepatitis A epidemiology of the countries in the WPR and reviewed the trends reported in the literature from the years 2000 to 2021. Many countries have shifted from high endemicity to low endemicity. Moreover, the administration of the hepatitis A vaccine among children in recent years has shifted disease susceptibility to the older population. Seroprevalence among children has decreased in most countries, while nearly 100% seropositivity is seen in mid adulthood. This is contrary to the epidemiology seen in previous decades when most children achieved immunity by age ten. This also presents a paradox in that better living conditions have caused more vulnerability to the older age groups who are at higher risk for severe disease. Given these trends, we recommend vaccination of vulnerable populations such as the older age groups and inclusion of the hepatitis A vaccine in government immunization programs.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article